K124055 is an FDA 510(k) clearance for the T1040 AKA AURAWAVE. Classified as Stimulator, Nerve, Transcutaneous, Over-the-counter (product code NUH), Class II - Special Controls.
Submitted by Endurance Therapeutics (Dauphin, Manitoba, CA). The FDA issued a Cleared decision on July 19, 2013 after a review of 200 days - an extended review cycle.
This device falls under the Neurology FDA review panel, regulated under 21 CFR 882.5890 - the FDA neurology device framework. The Traditional 510(k) pathway establishes clearance through substantial equivalence to a legally marketed predicate device, without requiring clinical trial data.
Device pattern: Standard predicate-based submission. Standard predicate reliance. This clearance follows a standard predicate-based equivalence path within the Neurology review framework, consistent with the majority of Class II 510(k) submissions.
View all Endurance Therapeutics devices